Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol

Ups J Med Sci. 2018 Jun;123(2):94-99. doi: 10.1080/03009734.2018.1465496. Epub 2018 May 10.

Abstract

Aims: To compare low-density lipoprotein cholesterol (LDL-C) values calculated by the Friedewald equation with direct LDL-C in patient samples and assess the possible impact on re-classification of LDL-C target values for primary prevention or high cardiovascular disease (CVD) risk (<2.5 mmol/L) and secondary prevention or very high CVD risk (<1.8 mmol/L). LDL-C is an important CVD risk factor. Over the last decade, there has been a change in laboratory methodology from indirectly calculated LDL-C with the Friedewald equation to direct LDL-C measurements (dLDL-C).

Methods: Reported results for plasma triglycerides, total cholesterol, high-density lipoprotein-cholesterol, and dLDL-C from 34,981 samples analyzed in year 2014 were extracted from the laboratory information system, Uppsala University Hospital, Uppsala, Sweden.

Results: dLDL-C was approximately 10% lower than the corresponding LDL-C results calculated by the Friedewald equation in both men and women. In subjects with triglyceride concentrations above 4 mmol/L (n = 1250) the same discordant pattern was seen as for the entire study population. Altogether 5469 out of 18,051 men (30.3%) and 4604 out of 16,928 women (27.2%) were down-classified at least one CVD risk category. A very small number of subject was up-classified, in total 37 out of 18,051 men (0.2%) and 28 out of 16,928 women (0.2%).

Conclusions: The two LDL-C methods had a high concordance, but the direct LDL-C measurement consistently gave approx. 10% lower values, and this caused one-third of subjects to be re-classified as having a lower cardiovascular disease risk in relation to recommended LDL-C target values and decision limits.

Keywords: Direct LDL-C measurement; Friedewald equation; LDL-cholesterol; primary prevention; re-classification; secondary prevention.

MeSH terms

  • Age Factors
  • Aged
  • Atherosclerosis / blood
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / diagnosis*
  • Cholesterol, LDL / blood*
  • Female
  • Hospitals, University
  • Humans
  • Male
  • Middle Aged
  • Primary Prevention / methods
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Sweden
  • Triglycerides / blood

Substances

  • Cholesterol, LDL
  • Triglycerides

Grants and funding

This study was supported by grants from the Swedish government under the agreement for medical education and research (ALF-medel).